Conserved oligopeptide permeases modulate sporulation initiation in clostridium difficile

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4276-4291

  Edwards, Adrianne N ^a   Nawrocki, Kathryn L ^a   McBride, Shonna M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOPEPTIDE; PERMEASE; CARRIER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL SPORE; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE INFECTION; FECES; FEMALE; HAMSTER MODEL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIENT AVAILABILITY; PATHOGENESIS; PEPTOCLOSTRIDIUM DIFFICILE; PHENOTYPE; QUORUM SENSING; SPOROGENESIS; ANIMAL; BACTERIAL LOAD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; MESOCRICETUS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VIRULENCE;

ANIMALS; BACTERIAL LOAD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CRICETINAE; DISEASE MODELS, ANIMAL; FECES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE KNOCKOUT TECHNIQUES; MEMBRANE TRANSPORT PROTEINS; MESOCRICETUS; OLIGOPEPTIDES; SPORES, BACTERIAL; VIRULENCE;

EID: 84907091588     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02323-14     Document Type: Article

References (99)

1. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD. 2012. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect. Immun. 80:2704-2711. http://dx.doi.org/10.1128/IAI.00147-12.
2. Paredes CJ, Alsaker KV, Papoutsakis ET. 2005. A comparative genomic view of clostridial sporulation and physiology. Nat. Rev. Microbiol. 3:969-978. http://dx.doi.org/10.1038/nrmicro1288.
3. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, Wilcox MH, Stephenson K. 2009. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J. Bacteriol. 191:7296-7305. http://dx.doi.org/10.1128/JB.00882-09.
4. Jones SW, Paredes CJ, Tracy B, Cheng N, Sillers R, Senger RS, Papoutsakis ET. 2008. The transcriptional program underlying the physiology of clostridial sporulation. Genome Biol. 9:R114. http://dx.doi.org/10.1186 /gb-2008-9-7-r114.
5. Steiner E, Scott J, Minton NP, Winzer K. 2012. An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum. Appl. Environ. Microbiol. 78:1113-1122. http://dx.doi.org/10.1128/AEM.06376-11.
6. Durre P, Hollergschwandner C. 2004. Initiation of endospore formation in Clostridium acetobutylicum. Anaerobe 10:69-74. http://dx.doi.org/10.1016/j.anaerobe.2003.11.001.
7. Paredes-Sabja D, Shen A, Sorg JA. 2014. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol. 22:406-416. http://dx.doi.org/10.1016/j.tim.2014.04.003.
8. Edwards AN, McBride SM. 9 June 2014. Initiation of sporulation in Clostridium difficile: a twist on the classic model. FEMS Microbiol. Lett. http://dx.doi.org/10.1111/1574-6968.12499.
9. Sonenshein AL. 2000. Control of sporulation initiation in Bacillus subtilis. Curr. Opin. Microbiol. 3:561-566. http://dx.doi.org/10.1016/S1369 -5274(00)00141-7.
10. Perego M, Hoch JA. 1996. Cell-cell communication regulates the effects of protein aspartate phosphatases on the phosphorelay controlling development in Bacillus subtilis. Proc. Natl. Acad. Sci. U. S. A. 93:1549-1553. http://dx.doi.org/10.1073/pnas.93.4.1549.
11. Magnuson R, Solomon J, Grossman AD. 1994. Biochemical and genetic characterization of a competence pheromone from B. subtilis. Cell 77: 207-216. http://dx.doi.org/10.1016/0092-8674(94)90313-1.
12. Lazazzera BA, Solomon JM, Grossman AD. 1997. An exported peptide functions intracellularly to contribute to cell density signaling in B. subtilis. Cell 89:917-925. http://dx.doi.org/10.1016/S0092-8674(00)80277-9.
13. Perego M. 1997. A peptide export-import control circuit modulating bacterial development regulates protein phosphatases of the phosphorelay. Proc. Natl. Acad. Sci. U. S. A. 94:8612-8617. http://dx.doi.org/10.1073/pnas.94.16.8612.
14. Perego M, Hanstein C, Welsh KM, Djavakhishvili T, Glaser P, Hoch JA. 1994. Multiple protein-aspartate phosphatases provide a mechanism for the integration of diverse signals in the control of development in B. subtilis. Cell 79:1047-1055. http://dx.doi.org/10.1016/0092 -8674(94)90035-3.
15. Hiles ID, Gallagher MP, Jamieson DJ, Higgins CF. 1987. Molecular characterization of the oligopeptide permease of Salmonella typhimurium. J. Mol. Biol. 195:125-142. http://dx.doi.org/10.1016/0022-2836(87)90332-9.
16. Pearce SR, Mimmack ML, Gallagher MP, Gileadi U, Hyde SC, Higgins CF. 1992. Membrane topology of the integral membrane components, OppB and OppC, of the oligopeptide permease of Salmonella typhimurium. Mol. Microbiol. 6:47-57. http://dx.doi.org/10.1111/j.1365-2958.1992.tb00836.x.
17. Pearce BJ, Naughton AM, Masure HR. 1994. Peptide permeases modulate transformation in Streptococcus pneumoniae. Mol. Microbiol. 12: 881-892. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01076.x.
18. Solomon JM, Lazazzera BA, Grossman AD. 1996. Purification and characterization of an extracellular peptide factor that affects two different developmental pathways in Bacillus subtilis. Genes Dev. 10:2014-2024. http://dx.doi.org/10.1101/gad.10.16.2014.
19. Ruhfel RE, Manias DA, Dunny GM. 1993. Cloning and characterization of a region of the Enterococcus faecalis conjugative plasmid, pCF10, encoding a sex pheromone-binding function. J. Bacteriol. 175:5253-5259.
20. Leonard BA, Podbielski A, Hedberg PJ, Dunny GM. 1996. Enterococcus faecalis pheromone binding protein, PrgZ, recruits a chromosomal oligopeptide permease system to import sex pheromone cCF10 for induction of conjugation. Proc. Natl. Acad. Sci. U. S. A. 93:260-264. http://dx.doi.org /10.1073/pnas.93.1.260.
21. Gominet M, Slamti L, Gilois N, Rose M, Lereclus D. 2001. Oligopeptide permease is required for expression of the Bacillus thuringiensis plcR regulon and for virulence. Mol. Microbiol. 40:963-975. http://dx.doi.org /10.1046/j.1365-2958.2001.02440.x.
22. Slamti L, Lereclus D. 2002. A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group. EMBO J. 21: 4550-4559. http://dx.doi.org/10.1093/emboj/cdf450.
23. Guyer CA, Morgan DG, Staros JV. 1986. Binding specificity of the periplasmic oligopeptide-binding protein from Escherichia coli. J. Bacteriol. 168:775-779.
24. Tame JR, Murshudov GN, Dodson EJ, Neil TK, Dodson GG, Higgins CF, Wilkinson AJ. 1994. The structural basis of sequence-independent peptide binding by OppA protein. Science 264:1578-1581. http://dx.doi.org/10.1126/science.8202710.
25. Kunji ER, Hagting A, De Vries CJ, Juillard V, Haandrikman AJ, Poolman B, Konings WN. 1995. Transport of beta-casein-derived peptides by the oligopeptide transport system is a crucial step in the proteolytic pathway of Lactococcus lactis. J. Biol. Chem. 270:1569-1574. http: //dx.doi.org/10.1074/jbc.270.4.1569.
26. Sleigh SH, Seavers PR, Wilkinson AJ, Ladbury JE, Tame JR. 1999. Crystallographic and calorimetric analysis of peptide binding to OppA protein. J. Mol. Biol. 291:393-415. http://dx.doi.org/10.1006/jmbi.1999.2929.
27. Lanfermeijer FC, Detmers FJ, Konings WN, Poolman B. 2000. On the binding mechanism of the peptide receptor of the oligopeptide transport system of Lactococcus lactis.EMBOJ. 19:3649-3656. http://dx.doi.org/10.1093/emboj/19.14.3649.
28. Nisman B, Raynaud M, Cohen GN. 1948. Extension of the Stickland reaction to several bacterial species. Arch. Biochem. 16:473.
29. Bouillaut L, Self WT, Sonenshein AL. 2013. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J. Bacteriol. 195:844- 854. http://dx.doi.org/10.1128/JB.01492-12.
30. Stickland LH. 1934. Studies in the metabolism of the strict anaerobes (genus Clostridium): the chemical reactions by which Cl. sporogenes obtains its energy. Biochem. J. 28:1746-1759.
31. Stickland LH. 1935. Studies in the metabolism of the strict anaerobes (genus Clostridium): the oxidation of alanine by Cl. sporogenes. IV. The reduction of glycine by Cl. sporogenes. Biochem. J. 29:889-898.
32. Stickland LH. 1935. Studies in the metabolism of the strict anaerobes (genus Clostridium): the reduction of proline by Cl. sporogenes. Biochem. J. 29:288-290.
33. Smith CJ, Markowitz SM, Macrina FL. 1981. Transferable tetracycline resistance in Clostridium difficile. Antimicrob. Agents Chemother. 19: 997-1003. http://dx.doi.org/10.1128/AAC.19.6.997.
34. Purcell EB, McKee RW, McBride SM, Waters CM, Tamayo R. 2012. Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile. J. Bacteriol. 194:3307-3316. http://dx.doi.org/10.1128 /JB.00100-12.
35. Sorg JA, Dineen SS. 2009. Laboratory maintenance of Clostridium difficile. Curr. Protoc. Microbiol. Chapter 9:Unit 9A.1. http://dx.doi.org/10.1002/9780471729259.mc09a01s12.
36. Putnam EE, Nock AM, Lawley TD, Shen A. 2013. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins. J. Bacteriol. 195: 1214-1225. http://dx.doi.org/10.1128/JB.02181-12.
37. Bouillaut L, McBride SM, Sorg JA. 2011. Genetic manipulation of Clostridium difficile. Curr. Protoc. Microbiol. Chapter 9:Unit 9A.2. http://dx.doi.org/10.1002/9780471729259.mc09a02s20.
38. Edwards AN, Suarez JM, McBride SM. 2013. Culturing and maintaining Clostridium difficile in an anaerobic environment. J. Vis. Exp. 2013: e50787. http://dx.doi.org/10.3791/50787.
39. Karlsson S, Burman LG, Akerlund T. 1999. Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 145(Pt 7):1683-1693. http://dx.doi.org/10.1099/13500872-145-7-1683.
40. Luria SE, Burrous JW. 1957. Hybridization between Escherichia coli and Shigella. J. Bacteriol. 74:461-476.
41. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10:R102. http://dx.doi.org/10.1186/gb-2009-10-9-r102.
42. Dineen SS, McBride SM, Sonenshein AL. 2010. Integration of metabolism and virulence by Clostridium difficile CodY. J. Bacteriol. 192:5350- 5362. http://dx.doi.org/10.1128/JB.00341-10.
43. Karberg M, Guo H, Zhong J, Coon R, Perutka J, Lambowitz AM. 2001. Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat. Biotechnol. 19:1162-1167. http://dx.doi.org/10.1038/nbt1201-1162.
44. Ho TD, Ellermeier CD. 2011. PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile. Infect. Immun. 79:3229-3238. http://dx.doi.org/10.1128/IAI.00019-11.
45. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. 2007. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70:452-464. http://dx.doi.org/10.1016/j.mimet.2007.05.021.
46. McBride SM, Sonenshein AL. 2011. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 157:1457-1465. http://dx.doi.org/10.1099/mic.0.045997-0.
47. Saujet L, Pereira FC, Serrano M, Soutourina O, Monot M, Shelyakin PV, Gelfand MS, Dupuy B, Henriques AO, Martin-Verstraete I. 2013. Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet. 9:e1003756. http: //dx.doi.org/10.1371/journal.pgen.1003756.
48. McBride SM, Sonenshein AL. 2011. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect. Immun. 79:167-176. http://dx.doi.org/10.1128/IAI.00731-10.
49. Suarez JM, Edwards AN, McBride SM. 2013. The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics. J. Bacteriol. 195:2621-2631. http://dx.doi.org/10.1128/JB.00166-13.
50. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108. http://dx.doi.org /10.1038/nprot.2008.73.
51. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. 1977. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 136:701-705. http://dx.doi.org/10.1093/infdis /136.5.701.
52. Chang TW, Bartlett JG, Gorbach SL, Onderdonk AB. 1978. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect. Immun. 20:526-529.
53. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786. http://dx.doi.org/10.1038/ng1830.
54. Monot M, Boursaux-Eude C, Thibonnier M, Vallenet D, Moszer I, Medigue C, Martin-Verstraete I, Dupuy B. 2011. Reannotation of the genome sequence of Clostridium difficile strain 630. J. Med. Microbiol. 60:1193-1199. http://dx.doi.org/10.1099/jmm.0.030452-0.
55. Doeven MK, Kok J, Poolman B. 2005. Specificity and selectivity determinants of peptide transport in Lactococcus lactis and other microorganisms. Mol. Microbiol. 57:640-649. http://dx.doi.org/10.1111/j.1365-2958.2005.04698.x.
56. Monnet V. 2003. Bacterial oligopeptide-binding proteins. Cell. Mol. Life Sci. 60:2100-2114. http://dx.doi.org/10.1007/s00018-003-3054-3.
57. Koide A, Hoch JA. 1994. Identification of a second oligopeptide transport system in Bacillus subtilis and determination of its role in sporulation. Mol. Microbiol. 13:417-426. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00436.x.
58. Peltoniemi K, Vesanto E, Palva A. 2002. Genetic characterization of an oligopeptide transport system from Lactobacillus delbrueckii subsp. bulgaricus. Arch. Microbiol. 177:457-467. http://dx.doi.org/10.1007/s00203 -002-0411-9.
59. Antunes A, Camiade E, Monot M, Courtois E, Barbut F, Sernova NV, Rodionov DA, Martin-Verstraete I, Dupuy B. 2012. Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucleic Acids Res. 40:10701-10718. http://dx.doi.org/10.1093/nar/gks864.
60. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I. 2011. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J. Bacteriol. 193:3186-3196. http://dx.doi.org/10.1128/JB.00272-11.
61. Perego M, Higgins CF, Pearce SR, Gallagher MP, Hoch JA. 1991. The oligopeptide transport system of Bacillus subtilis plays a role in the initiation of sporulation. Mol. Microbiol. 5:173-185. http://dx.doi.org/10.1111/j.1365-2958.1991.tb01838.x.
62. Rudner DZ, LeDeaux JR, Ireton K, Grossman AD. 1991. The spo0K locus of Bacillus subtilis is homologous to the oligopeptide permease locus and is required for sporulation and competence. J. Bacteriol. 173:1388- 1398.
63. Burns DA, Heap JT, Minton NP. 2010. The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16:618-622. http://dx.doi.org/10.1016/j.anaerobe.2010.10.001.
64. Boudry P, Gracia C, Monot M, Caillet J, Saujet L, Hajnsdorf E, Dupuy B, Martin-Verstraete I, Soutourina O. 30 June 2014. Pleiotropic role of the RNA chaperone protein Hfq in the human pathogen Clostridium difficile. J. Bacteriol. http://dx.doi.org/10.1128/JB.01923-14.
65. Pogliano J, Osborne N, Sharp MD, Abanes-De Mello A, Perez A, Sun YL, Pogliano K. 1999. A vital stain for studying membrane dynamics in bacteria: a novel mechanism controlling septation during Bacillus subtilis sporulation. Mol. Microbiol. 31:1149-1159. http://dx.doi.org/10.1046/j.1365-2958.1999.01255.x.
66. McBride SM, Rubio A, Wang L, Haldenwang WG. 2005. Contributions of protein structure and gene position to the compartmentalization of the regulatory proteins sigma(E) and SpoIIE in sporulating Bacillus subtilis. Mol. Microbiol. 57:434-451. http://dx.doi.org/10.1111/j.1365-2958.2005.04712.x.
67. Chastanet A, Losick R. 2011. Just-in-time control of Spo0A synthesis in Bacillus subtilis by multiple regulatory mechanisms. J. Bacteriol. 193: 6366-6374. http://dx.doi.org/10.1128/JB.06057-11.
68. Errington J. 2003. Regulation of endospore formation in Bacillus subtilis. Nat. Rev. Microbiol. 1:117-126. http://dx.doi.org/10.1038/nrmicro750.
69. Fimlaid KA, Bond JP, Schutz KC, Putnam EE, Leung JM, Lawley TD, Shen A. 2013. Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet. 9:e1003660. http://dx.doi.org/10.1371/journal.pgen.1003660.
70. Pereira FC, Saujet L, Tome AR, Serrano M, Monot M, Couture-Tosi E, Martin-Verstraete I, Dupuy B, Henriques AO. 2013. The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet. 9:e1003782. http://dx.doi.org/10.1371/journal.pgen.1003782.
71. Haldenwang WG. 1995. The sigma factors of Bacillus subtilis. Microbiol. Rev. 59:1-30.
72. Satola S, Kirchman PA, Moran CP, Jr. 1991. Spo0A binds to a promoter used by sigma A RNA polymerase during sporulation in Bacillus subtilis. Proc. Natl. Acad. Sci. U. S. A. 88:4533-4537. http://dx.doi.org/10.1073 /pnas.88.10.4533.
73. Rong S, Rosenkrantz MS, Sonenshein AL. 1986. Transcriptional control of the Bacillus subtilis spoIID gene. J. Bacteriol. 165:771-779.
74. Haraldsen JD, Sonenshein AL. 2003. Efficient sporulation in Clostridium difficile requires disruption of the sigmaK gene. Mol. Microbiol. 48:811- 821. http://dx.doi.org/10.1046/j.1365-2958.2003.03471.x.
75. Koide A, Perego M, Hoch JA. 1999. ScoC regulates peptide transport and sporulation initiation in Bacillus subtilis. J. Bacteriol. 181:4114-4117.
76. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. 2007. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66:206 -219. http://dx.doi.org/10.1111/j.1365-2958.2007.05906.x.
77. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79: 882-899. http://dx.doi.org/10.1111/j.1365-2958.2010.07495.x.
78. Dupuy B, Sonenshein AL. 1998. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 27:107-120. http://dx.doi.org/10.1046/j.1365-2958.1998.00663.x.
79. Sonenshein AL. 2007. Control of key metabolic intersections in Bacillus subtilis. Nat. Rev. Microbiol. 5:917-927. http://dx.doi.org/10.1038 /nrmicro1772.
80. Chateau A, van Schaik W, Joseph P, Handke LD, McBride SM, Smeets FM, Sonenshein AL, Fouet A. 2013. Identification of CodY targets in Bacillus anthracis by genome-wide in vitro binding analysis. J. Bacteriol. 195:1204-1213. http://dx.doi.org/10.1128/JB.02041-12.
81. Chiang C, Bongiorni C, Perego M. 2011. Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA. J. Bacteriol. 193:52-62. http://dx.doi.org/10.1128/JB.01656-09.
82. Mandic-Mulec I, Doukhan L, Smith I. 1995. The Bacillus subtilis SinR protein is a repressor of the key sporulation gene spo0A. J. Bacteriol. 177: 4619-4627.
83. Bai U, Mandic-Mulec I, Smith I. 1993. SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by proteinprotein interaction. Genes Dev. 7:139-148. http://dx.doi.org/10.1101/gad.7.1.139.
84. Janoir C, Deneve C, Bouttier S, Barbut F, Hoys S, Caleechum L, Chapeton-Montes D, Pereira F, Henriques A, Collignon A, Monot M, Dupuy B. 2013. Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect. Immun. 81:3757-3769. http: //dx.doi.org/10.1128/IAI.00515-13.
85. Wilson KH, Sheagren JN, Freter R. 1985. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J. Infect. Dis. 151:355-361. http://dx.doi.org/10.1093/infdis/151.2.355.
86. Douce G, Goulding D. 2010. Refinement of the hamster model of Clostridium difficile disease. Methods Mol. Biol. 646:215-227. http://dx.doi.org/10.1007/978-1-60327-365-7_14.
87. Best EL, Freeman J, Wilcox MH. 2012. Models for the study of Clostridium difficile infection. Gut Microbes 3:145-167. http://dx.doi.org/10.4161/gmic.19526.
88. Razaq N, Sambol S, Nagaro K, Zukowski W, Cheknis A, Johnson S, Gerding DN. 2007. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J. Infect. Dis. 196:1813-1819. http://dx.doi.org/10.1086/523106.
89. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713. http://dx.doi.org/10.1038/nature09397.
90. Yamakawa K, Karasawa T, Ikoma S, Nakamura S. 1996. Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J. Med. Microbiol. 44:111-114. http://dx.doi.org/10.1099/00222615-44-2 -111.
91. Errington J. 1993. Bacillus subtilis sporulation: regulation of gene expression and control of morphogenesis. Microbiol. Rev. 57:1-33.
92. Gaur NK, Cabane K, Smith I. 1988. Structure and expression of the Bacillus subtilis sin operon. J. Bacteriol. 170:1046-1053.
93. Mathiopoulos C, Mueller JP, Slack FJ, Murphy CG, Patankar S, Bukusoglu G, Sonenshein AL. 1991. A Bacillus subtilis dipeptide transport system expressed early during sporulation. Mol. Microbiol. 5:1903-1913. http://dx.doi.org/10.1111/j.1365-2958.1991.tb00814.x.
94. Caldwell R, Sapolsky R, Weyler W, Maile RR, Causey SC, Ferrari E. 2001. Correlation between Bacillus subtilis scoC phenotype and gene expression determined using microarrays for transcriptome analysis. J. Bacteriol. 183:7329-7340. http://dx.doi.org/10.1128/JB.183.24.7329-7340.2001.
95. George WL, Sutter VL, Citron D, Finegold SM. 1979. Selective and differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 9:214-219.
96. Wilson KH, Silva J, Fekety FR. 1981. Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect. Immun. 34:626-628.
97. Wust J, Hardegger U. 1983. Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile. Antimicrob. Agents Chemother. 23:784-786. http://dx.doi.org/10.1128/AAC.23.5.784.
98. Hussain HA, Roberts AP, Mullany P. 2005. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J. Med. Microbiol. 54: 137-141. http://dx.doi.org/10.1099/jmm.0.45790-0.
99. Thomas CM, Smith CA. 1987. Incompatibility group P plasmids: genetics, evolution, and use in genetic manipulation. Annu. Rev. Microbiol. 41:77-101. http://dx.doi.org/10.1146/annurev.mi.41.100187.000453.